XML 33 R19.htm IDEA: XBRL DOCUMENT v3.19.1
Note 11 - Stock-based Compensation
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
11
. S
tock
-Based
Compensation
 
Equity Incentive Plans
 
 
We adopted the following stockholder-approved equity incentive plans:
 
●        The
1996
Amended Stock Incentive Plan (the
“1996
Plan”) authorized the issuance of up to
5.0
million shares of our common stock covering several different types of awards, including stock options, restricted shares, stock appreciation rights, performance shares, and phantom stock. The
1996
Plan was terminated in
2006.
Options granted before termination of the
1996
Plan will continue to remain outstanding until exercised, cancelled, or expired.
 
●          The
2005
Stock Incentive Plan (the
“2005
Plan”), which authorized the issuance of up to
11.45
million shares of common stock covering several different types of awards, including stock options, restricted shares, stock appreciation rights, performance shares, and phantom stock. The
2005
Plan was terminated in
June 2018
at the time the
2018
Stock Incentive Plan was approved. Shares available for new awards under the
2005
Plan at the time of termination became available for awards under the
2018
Stock Incentive Plan. Options granted before termination of the
2005
Plan will continue to remain outstanding until exercised, cancelled or expired.
 
●          The
2018
Performance Incentive Plan (the
“2018
Plan”), pursuant to which we are authorized to issue up to
4.8
million shares of common stock covering several different types of awards, including stock options, restricted shares, stock appreciation rights, performance shares, and phantom stock. The
2018
Plan will terminate on
March 27, 2028.
 
The stock option plans provide that options
may
be granted at an exercise price of
100%
of fair market value of our common stock on the date of grant,
may
be exercised in full or in installments, at the discretion of the Board or its Compensation Committee, and must be exercised within
ten
years from date of grant. Stock options generally vest pro rata over
three
to
five
years. We recognize stock-based compensation expense on a straight-line basis over the requisite service (vesting) period based on fair values. We use historical data to estimate expected employee behaviors related to option exercises and forfeitures and included these expected forfeitures as a part of the estimate of stock-based compensation expense as of the grant date. We adjust the total amount of stock-based compensation expense recognized for each award, in the period in which each award vests, to reflect the actual forfeitures related to that award. Changes in our estimated forfeiture rate will result in changes in the rate at which compensation cost for an award is recognized over its vesting period.
 
Stock Options
 
The following table summarizes stock options activity for the year ended
December 31, 2018:
 
   
 
 
 
 
 
 
 
 
Weighted
 
   
 
 
 
 
Weighted
   
Average
 
   
Number
   
Average
   
Remaining
 
   
of Shares
   
Exercise Price
   
Contractual Life
 
Outstanding at January 1, 2018
   
5,535
    $
7.25
     
6.04
 
Granted
   
1,566
    $
6.93
     
 
 
Exercised
   
(96
)   $
4.85
     
 
 
Cancelled
   
(483
)   $
7.97
     
 
 
Expired
   
(258
)   $
16.05
     
 
 
Outstanding at December 31, 2018
 
 
6,264
   
$
6.79
   
 
6.02
 
Exercisable at December 31, 2018
 
 
4,242
   
$
6.42
   
 
4.78
 
Vested and expected to vest at December 31, 2018
 
 
5,887
   
$
6.75
   
 
5.84
 
 
The weighted average fair value of options granted during
2018,
2017,
and
2016
was
$4.56,
$6.96,
and
$3.24
per share, respectively.
 
The total intrinsic value (the excess of the market price over the exercise price) for stock options outstanding, exercisable, and vested and expected to vest, was
zero
as of
December 31, 2018.
The total intrinsic value for stock options exercised during
2018,
2017,
and
2016
was
$173
thousand,
$233
thousand, and
$476
thousand, respectively.
 
Stock-Based Compensation Expense
 
We account for stock-based awards issued to employees in accordance with the provisions of ASC
718
(Topic
718,
Compensation – Stock Compensation
). We recognize stock-based compensation expense on a straight-line basis over the service period of the award, which is generally
three
to
five
years. Stock-based awards issued to consultants are accounted for in accordance with the provisions of ASC
718
and ASC
505
-
50
(Subtopic
50
"Equity-Based Payments to Non-Employees" of Topic
505,
Equity
). Options granted to consultants are periodically revalued as the options vest, and are recognized as an expense over the related period of service or the vesting period, whichever is longer. Under the provisions of ASC
718,
members of the Board are considered employees for calculation of stock-based compensation expense.
 
We estimated the fair value of the stock options granted on the date of grant using a Black-Scholes valuation model that used the weighted average assumptions noted in the following table. The risk-free interest rate assumption we use is based upon U.S. Treasury interest rates appropriate for the expected life of the awards. The expected life (estimated period of time that we expect employees, directors, and consultants to hold their stock options) was estimated based on historical rates for
three
group classifications, (i) employees, (ii) outside directors and officers, and (iii) consultants. Expected volatility was based on historical volatility of our stock price for a period equal to the stock option's expected life and calculated on a daily basis. The expected dividend rate is
zero
since we do
not
currently pay cash dividends on our common stock and do
not
anticipate doing so in the foreseeable future.
 
The following table presents assumptions used in computing the fair value of option grants during
2018,
2017,
and
2016:
 
   
2018
   
2017
   
2016
 
Risk-free interest rate
   
2.72%
     
2.17%
     
1.53%
 
Expected life (in years)
   
6.67
     
6.76
     
6.77
 
Expected volatility
   
69%
     
72%
     
74%
 
Expected dividend yield
 
 
--
   
 
--
   
 
--
 
 
Stock-based compensation expense for the years ended
December 31, 2018,
2017,
and
2016
was recorded in our consolidated statement of operations as follows:
 
   
2018
   
2017
   
2016
 
Research and development expenses
  $
1,760
    $
1,371
    $
843
 
General and administrative expenses
   
3,449
     
2,771
     
1,614
 
Total stock-based compensation expense
 
$
5,209
   
$
4,142
   
$
2,457
 
 
At
December 31, 2018,
unrecognized stock-based compensation expense related to stock options was approximately
$5.2
million and is expected to be recognized over a weighted average period of approximately
2.1
years.